Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Drug discovery researcher Professor Paul Workman awarded prestigious AAAS Fellowship 31
Jan
2023

Professor Paul Workman, former Chief Executive and President of The Institute of Cancer Research, London, from 2014 to 2021, has been elected as a Fellow of the American Association for the Advancement of Science (AAAS), one of the most distinguished honours in the scientific community. Find out more

Experts call for better cancer tests to tailor treatment 30
Jan
2023

Greater use of cancer tests is the key to tailoring use of new treatments for patients more precisely and so increasing their chances of being recommended for use within the NHS, experts say. Find out more

Travel boost for The London Cancer Hub as number of trains set to double 27
Jan
2023

The number of trains serving The London Cancer Hub’s local rail station, Belmont, is set to double thanks to £14m from the Government’s Levelling Up Fund. Find out more

See all news articles

Features

“A challenge for a challenge”: Meet the cyclists funding our secondary breast cancer research 20
Jan
2023

Cyclist Christine O’Connell set up the One More City campaign shortly before she was diagnosed with stage 4 breast cancer in 2018. She and her teammates are now riding to fund a PhD studentship at The Institute of Cancer Research. Find out more

Scientific achievements of 2022 12
Dec
2022

We have picked 10 exciting scientific discoveries from the past academic year that brilliantly showcase the quality, breadth and strategic impact of our research. Find out more

Capivasertib – a huge success story for UK science 08
Dec
2022

The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Henry French gives an update Find out more

See all feature articles